

share
Solanezumab CAS NO 955085-14-0
Unit Price:
CAS No.:955085-14-0
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
Solanezumab CAS NO 955085-14-0 is a humanized monoclonal antibody designed to target soluble amyloid-beta peptides. This product is of significant interest in the research and development of novel therapeutic strategies for neurodegenerative conditions. It is primarily utilized by pharmaceutical R&D teams, biotechnology companies, and academic research institutions focused on neuroscience and immunology.
Application
- Biopharmaceutical Research: Key reagent in the study of amyloid-beta pathology and Alzheimer's disease mechanisms.
- Therapeutic Development: Used in preclinical studies for the formulation and efficacy testing of potential neuroprotective treatments.
- Immunoassay Development: Serves as a critical component in the development of diagnostic assays for detecting specific amyloid-beta isoforms.
- Cell Culture & In Vitro Studies: Applied in cellular models to investigate antibody-mediated clearance of soluble protein aggregates.
- Reference Standard: Acts as a high-purity biological reference material for quality control and method validation in related bioanalytical workflows.
Basic Information
| Product Name | Solanezumab |
| CAS No. | 955085-14-0 |
| Molecular Formula | C6470H10012N1736O2010S44 |
| Molecular Weight | Approx. 146 kDa |
| Synonyms | LY2062430; Anti-Amyloid Beta, Soluble, Monoclonal Antibody; h4G8; Solanezumab (USAN/INN); IgG1, anti-(human amyloid beta peptide) (human γ1-chain), disulfide with human λ-chain, dimer |
| EINECS | Contact for details |
Quality Control
Our Solanezumab is manufactured under stringent conditions to ensure the highest standards of purity and biological activity. Each batch undergoes comprehensive analytical testing, including SDS-PAGE, SEC-HPLC for purity and aggregation analysis, peptide mapping, and endotoxin testing. Certificates of Analysis (COA) detailing identity, purity, potency, and safety profiles are available upon request to support your regulatory and research needs.
Storage
Preserve in a tightly closed container, protected from light. For long-term stability, store at -20°C to -80°C. Avoid repeated freeze-thaw cycles. This product is hygroscopic (moisture-sensitive) and should be handled under appropriate conditions to maintain stability.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white lyophilized powder or clear solution |
| Identification (Mass Spec) | Conforms |
| Purity (SEC-HPLC) | ≥ 95.0% (Monomer) |
| Protein Content (A280) | As per COA |
| Endotoxin | < 1.0 EU/mg |
| Biological Activity (Binding ELISA) | Conforms |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Pembrolizumab CAS NO 1374853-91-4


Tuvirumab CAS NO 138660-97-6


Biciromab CAS NO 138783-13-8


Muromonab-Cd3 CAS NO 140608-64-6


Anti-Stromelysin-2 CAS NO 140610-48-6


Gendevit CAS NO 141910-80-7


Edrecolomab CAS NO 156586-89-9


Felvizumab CAS NO 167747-20-8


Faralimomab CAS NO 167816-91-3


Rovelizumab [Usan:Inn] CAS NO 197099-66-4


Teprotumumab CAS NO 1036734-93-6


Monalizumab CAS NO 1228763-95-8


Anifrolumab CAS NO 1326232-46-5


Anti-Br140-Like Protein Antibody Produced In Rabbit CAS NO 1597439-92-3


Eptinezumab CAS NO 1644539-04-7


Rhumab Cd 168 CAS NO 211323-03-4


Ociperlimab CAS NO 2342597-93-5


Tadocizumab CAS NO 339086-80-5


Galiximab CAS NO 357613-77-5


Tocilizumab CAS NO 375823-41-9
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






